Low risk of viral infection after administration of vapor-heated factor VIII concentrate

P. M. Mannucci, K. Schimpf, T. Abe, L. M. Aledort, K. Anderle, D. B. Brettler, M. W. Hilgartner, P. B A Kernoff, M. Kunschak, C. W. McMillan, F. E. Preston, G. E. Rivard, W. Muntean, H. Vinazzer, H. Schmitt, C. Durin, Y. Sultin, T. Nagao, J. Mimaya

Research output: Contribution to journalArticle

Abstract

A multicenter prospective study was carried out to evaluate whether a vapor-heated factor VIII concentrate transmitted blood-borne viral infections over a surveillance period of 15 months. Thirty-five patients with hemophilia and von Willebrand disease who had never received any blood components were treated. Twenty-eight were analyzed and found not to have non-A, non-B hepatitis. Sera from 20 of these 28 patients were also tested for the antibody to the hepatitis C virus. None had sero-converted during the follow- up period. None of the patients analyzed developed markers of the hepatitis B virus (n = 17) or the human immunodeficiency virus (n = 31). This vapor- heated factor VIII concentrate carries a low risk of transmitting hepatitis and human immunodeficiency virus infection.

Original languageEnglish
Pages (from-to)134-138
Number of pages5
JournalTransfusion
Volume32
Issue number2
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Immunology
  • Hematology

Fingerprint Dive into the research topics of 'Low risk of viral infection after administration of vapor-heated factor VIII concentrate'. Together they form a unique fingerprint.

  • Cite this

    Mannucci, P. M., Schimpf, K., Abe, T., Aledort, L. M., Anderle, K., Brettler, D. B., Hilgartner, M. W., Kernoff, P. B. A., Kunschak, M., McMillan, C. W., Preston, F. E., Rivard, G. E., Muntean, W., Vinazzer, H., Schmitt, H., Durin, C., Sultin, Y., Nagao, T., & Mimaya, J. (1992). Low risk of viral infection after administration of vapor-heated factor VIII concentrate. Transfusion, 32(2), 134-138.